Skip to main content

Scientech Research LLC

Source: SEC Form 13F · as of Mar 2026

Scientech Research LLC holds 42 biotech & pharma companies tracked by BioSniper, totaling $11.6M in value as of Mar 2026 (SEC Form 13F).

Companies held

42

Total value held

$11.6M

BioSniper AIPage evidence connected

Prepared research question

What matters most for Scholar Rock Holding Corp (SRRK)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

CompanySharesValue
SRRKScholar Rock Holding Corp26,288$1.3M
VRDNViridian Therapeutics, Inc.\DE65,080$1.3M
CTMXCytomX Therapeutics, Inc.230,598$1.1M
NKTRNEKTAR THERAPEUTICS11,032$794K
ALMSALUMIS INC.29,405$648K
ELVNEnliven Therapeutics, Inc.15,827$620K
IOVAIOVANCE BIOTHERAPEUTICS, INC.138,148$485K
SYRESpyre Therapeutics, Inc.7,088$358K
GMABGenmab A/S13,109$352K
OCGNOcugen, Inc.188,525$341K
GPCRStructure Therapeutics Inc.6,958$335K
DAWNDay One Biopharmaceuticals, Inc.14,342$307K
CLDXCelldex Therapeutics, Inc.9,502$301K
ARGXARGENX SE348$254K
ZBIOZenas BioPharma, Inc.12,952$253K
COGTCogent Biosciences, Inc.5,919$228K
ADMAADMA BIOLOGICS, INC.23,756$214K
NTLAIntellia Therapeutics, Inc.16,265$209K
GERNGERON CORP133,846$199K
IBRXImmunityBio, Inc.25,768$198K
EDSAEdesa Biotech, Inc.30,534$160K
BHVNBiohaven Ltd.17,466$148K
SLDBSolid Biosciences Inc.20,409$147K
SLSSELLAS Life Sciences Group, Inc.34,096$144K
ARDXARDELYX, INC.17,799$107K
RLMDRELMADA THERAPEUTICS, INC.14,609$102K
ANNXAnnexon, Inc.17,316$96K
ESPREsperion Therapeutics, Inc.33,009$90K
CMPXCompass Therapeutics, Inc.16,669$88K
KURAKura Oncology, Inc.10,351$84K
RXRXRECURSION PHARMACEUTICALS, INC.26,902$83K
ABSIAbsci Corporation26,285$79K
CMPSCOMPASS Pathways plc13,037$72K
ALTAltimmune, Inc.21,840$67K
NUVBNuvation Bio Inc.15,017$64K
XERSXeris Biopharma Holdings, Inc.10,414$60K
CAMPCamp4 Therapeutics Corp12,735$56K
AQSTAquestive Therapeutics, Inc.13,181$55K
CATXPerspective Therapeutics, Inc.11,905$50K
SABSSAB BIOTHERAPEUTICS, INC.10,816$41K
PHIOPhio Pharmaceuticals Corp.30,032$37K
IMUXIMMUNIC, INC.26,635$30K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.